Dr. James E. Appel, MD

Dr. Appel practices at Wilmington Health in Wilmington, North Carolina.

Dr. Appel's NPI, 1457357204, was assigned on June 27, 2005. Dr. Appel graduated from University of Kentucky College of Medicine in 1995. Dr. Appel holds North Carolina license 2011-01732.

Dr. Appel's primary practice is Wilmington Health, at 1202 Medical Center Dr, Wilmington, NC 28401 in New Hanover County. The practice phone is (910) 341-3300.

Dr. Appel's primary practice is Wilmington Health in Wilmington, North Carolina. The medical group on file is Wilmington Health. Dmand AI also links Dr. Appel to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Appel practices. Vendor and product names are available with a free account.

Dermatology is Dr. Appel's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Appel is licensed in North Carolina.

CMS data shows 5,435 Medicare services from Dr. Appel across 34 procedure codes in 2024, for 1,147 Medicare patients. Medicare paid $211,237 for them. Every service was in an office.

CMS counts 1,147 Medicare patients who saw Dr. Appel in 2024. The largest group is 65 to 74, with 544 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Appel's median patient age at 72, with 47% women.

In 2024, Dr. Appel wrote 1,931 Medicare Part D claims for 603 patients. 91% of them were for generic drugs. CMS names the drug for 1,727 of them, across 30 drugs with 11 or more claims each, at $748,875 in total drug cost. In 2023, CMS named 1,465 claims across 25 drugs.

Dr. Appel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,418 procedures of removal of skin lesions by Dr. Appel, more than 96% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Appel in 2020. The most frequent topics are Skin Neoplasms. Dr. Appel's most frequent co-authors are Oleg E. Akilov, MD, PhD, Neal Kumar Bhatia, MD and Erin Elizabeth Boh, MD, PhD.

Dmand AI links Dr. Appel to 4 clinical trials. Conditions studied include Psoriasis, Skin Diseases, Papulosquamous and Eczema. Eli Lilly and Company sponsors the most, 4. Open Payments lists research payments to Dr. Appel that name 1 trial.

CMS Open Payments shows 406 general payments to Dr. Appel from 38 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Abbvie Inc. paid the most, $1,585. It also lists 5 research payments totaling $28,236 from 2018 to 2019, naming 1 clinical trial.

Dr. Appel graduated from University of Kentucky College of Medicine in 1995.